• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TRIVIDIA HEALTH, INC. TRUETRACK; BLOOD GLUCOSE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TRIVIDIA HEALTH, INC. TRUETRACK; BLOOD GLUCOSE SYSTEM Back to Search Results
Model Number TRUETRACK
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 12/04/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Product not yet returned for evaluation.Most likely underlying root cause: mlc-55-user had an inaccurate reference: competitor's meter: the end user is comparing results obtained from trividia's bgm system to the results from a competitor's bgm system.Test strip udi# (b)(4).Manufacturer contacted customer (several attempts) in a follow-up call to ensure that the replacement products resolved the initial concern - unable to establish contact with the customer at this time.Product notification letter sent to customer to contact customer care.
 
Event or Problem Description
Consumer reported complaint for high blood glucose test results.The customer is concerned with tests results from results obtained of 323 and 219 mg/dl.The customer's expected fasting blood glucose test result range is 100 - 150 mg/dl.Customer was comparing results to another device and stated the results obtained using the truetrack meter were higher; actual meter to meter comparison results were not provided.The customer feels well and did not report any symptoms.Medical attention is not reported as a result of the actual blood glucose results.The customer declined to perform a back to back blood test during call on (b)(6) 2018.The product is stored according to specification in the living room.The test strip lot manufacturer's expiration date is 01/30/2021 and open vial date is (b)(6) 2018.The meter memory was reviewed for previous test result history: result 1 :147mg/dl date: (b)(6) 2018 time:05:58am fasting; result 2 :323mg/dl date: (b)(6) 2018 time:10:54pm fasting; result 3 :219mg/dl date: (b)(6) 2018 time:02:33pm fasting; result 4 :173mg/dl date: (b)(6) 2018 time:12:01pm fasting; result 5 :172mg/dl date: (b)(6) 2018 time:06:12am fasting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRUETRACK
Common Device Name
BLOOD GLUCOSE SYSTEM
Manufacturer (Section D)
TRIVIDIA HEALTH, INC.
2400 nw 55th court
fort lauderdale FL 33309
MDR Report Key8199291
Report Number1000113657-2018-01288
Device Sequence Number13488185
Product Code NBW
UDI-Device Identifier00021292001018
UDI-Public(01)00021292001018
Combination Product (Y/N)N
Initial Reporter StateAR
PMA/510(K) Number
K032657
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial
Report Date (Section B) 12/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date01/30/2021
Device Model NumberTRUETRACK
Device Catalogue NumberA4H01-81
Device Lot NumberRV5290
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Event Location Home
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/04/2018
Initial Report FDA Received Date12/27/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SECOND THERAPY
-
-